Patent granted to Cotton Inc
Specific Patent Information
Patent Number | Title, Independent Claims and Summary of Claims | Assignee | ||||
---|---|---|---|---|---|---|
US 5994624
|
Title – In planta method for the production of transgenic plants
The United States patent 5 994 624 discloses
The transformed floral tissue develops normally, forming seeds after pollination. Seeds are grown to generate a F1 transformed progeny. Although claim 1 says that the injection device can be adapted for the injection of small volumes of material in a precise manner without causing massive tissue damage, it does not have to be. The specification, further, does not explicitly define what “massive tissue damage” is though it discloses that direct injection with a needle or particle bombardment can cause such damage. |
Cotton Inc. |
||||
AU 752717
|
Title – In planta method for the production of transgenic plants
Unlike the US patent, the claims in the AU patent do not require that the needleless injection device be a hypodermic device. As in the US patent, although claim 1 and 12 say that the needleless injection device can be adapted for the injection of small volumes of material in a precise manner without causing massive tissue damage, the claims don’t require the injection device to have these features/functions. The patent does not disclose what “excessive” tissue damage is other than to generally describe that it may occur through using a needle to inject a tissue. The patent does not explicitly state that “excessive” tissue damage and “massive” tissue damage are the same. |
|||||
Remarks | Related patent application in South Africa (ZA 9809517). |
Note: Patent information on this page was last updated on 22 February 2006.